Bay Area's Viveve Plans to Raise $13 Million in IPO

Viveve Medical (VIVE) plans to raise $13 million in an initial public offering on Tuesday, June 14th. The company plans to issue 1,600,000 shares at $8.00 per share.

In the last 12 months, Viveve Medical generated $2.7 million in revenue and had a net loss of $14 million. The company has a market-cap of $76.8 million.

Ladenburg Thalmann and Craig-Hallum Capital Group served as the underwriters for the IPO and Maxim Group was co-manager.

Back to news